Last reviewed · How we verify
Placebo for Linaclotide — Competitive Intelligence Brief
phase 3
Small molecule
Live · refreshed every 30 min
Target snapshot
Placebo for Linaclotide (Placebo for Linaclotide) — AbbVie. This is a placebo control, containing no active pharmaceutical ingredient and therefore has no mechanistic action.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Placebo for Linaclotide TARGET | Placebo for Linaclotide | AbbVie | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Placebo for Linaclotide CI watch — RSS
- Placebo for Linaclotide CI watch — Atom
- Placebo for Linaclotide CI watch — JSON
- Placebo for Linaclotide alone — RSS
Cite this brief
Drug Landscape (2026). Placebo for Linaclotide — Competitive Intelligence Brief. https://druglandscape.com/ci/placebo-for-linaclotide. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab